distinguished fellow

Amgen Investors Waiting for More Results on D-mab

A well written article easily understood. I would have appreciated reading the reason 'mab' has become generally added onto meds derived via monoclonal anti-bodies. If that is the case, and it certainly sounds logical, while it makes sense, how'd that happen?
The Doctor.